Tag archive
33% of lymphoma patients never receive their CAR-T infusion because manufacturing fails first. The root cause: a 4-marker QC system in a 36-marker world. Here's what I found when I went looking for an
A 36-marker spectral panel can predict CAR-T product quality. Next-day manufacturing needs QC in hours. Manual analysis takes days. The math doesn't work — unless AI closes the gap. Part 7 of the Flow
CAR-T cell therapy costs $500K per dose with a 30-day manufacturing bottleneck. Flow cytometry QC — still largely manual — is the rate-limiting step. As next-day manufacturing emerges, AI-automated an
Cytek Biosciences just posted record Q4 revenue but EBITDA collapsed 78%. With 3,664 instruments, 24K Cloud users, and zero AI announcements, the spectral cytometry pioneer faces an existential softwa
Fisher Vector encodes how data deviates from a generative model by computing gradients of log-likelihood. Originally designed for image classification, this elegant mathematical framework now achieves
AHEAD Medicine's patented GMM→Fisher Vector→SVM pipeline achieves 98% accuracy in AML diagnosis. Flow Monkey's agentic approach reasons through novel panels without retraining. We dissect both archite
NIST's FCSC has 60 members including Pfizer, FDA, and your competitors. WG5 is building AI-ready reference datasets. If you're building AI for flow cytometry, this consortium determines what 'validate
A thoracic surgeon and his AI agent searched PubMed for "agentic flow cytometry" — and found nothing. Zero papers. That gap isn't a dead end; it's the opportunity. Here's what we found when we dug dee
We mapped every AI-powered flow cytometry tool on the market — FlowJo, OMIQ, AHEAD Cyto-copilot, UNITO, flowMagic, CellCNN, DeepCyTOF — and found they all solve the same problem: automated gating. Flo
Spectral flow cytometry generates unprecedented volumes of high-dimensional immune data. AI and machine learning are automating analysis, replacing subjective manual gating, and unlocking clinical ins
NIST, FDA, and NIAID convened a first-of-its-kind workshop to address a crisis hiding in plain sight: millions of flow cytometry datasets are unusable for AI. We traced the evidence trail from 211,359